Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipranavir/ritonavir dose simplification in virologically suppressed HIV-1 patients
2006-006117-32Phase 3Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tipranavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoints: Primary efficacy endpoint and Virologic failure incidence. Started Dec 2006; status: terminated.
02
Drugs
tipranavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-006117-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006117-32.